The contemporary management of cancers of the sinonasal tract in adults
Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …
Update from the 5th Edition of the World Health Organization classification of head and neck tumors: nasal cavity, paranasal sinuses and skull base
LDR Thompson, JA Bishop - Head and Neck Pathology, 2022 - Springer
Abstract The World Health Organization Classification of Head and Neck Tumours recently
published the 5th edition. There are new entities, emerging entities, and significant updates …
published the 5th edition. There are new entities, emerging entities, and significant updates …
[HTML][HTML] Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE
Lutathera® is the first EMA-and FDA-approved radiopharmaceutical for radioligand therapy
(RLT). Currently, on the legacy of the NETTER1 trial, only adult patients with progressive …
(RLT). Currently, on the legacy of the NETTER1 trial, only adult patients with progressive …
[HTML][HTML] Challenges and future options for the production of lutetium-177
WV Vogel, SC Van der Marck… - European Journal of …, 2021 - Springer
The use of the medical isotope lutetium-177 is increasing, but there are concerns that its
worldwide availability may not be sufficient in the long term. This warrants an evaluation of …
worldwide availability may not be sufficient in the long term. This warrants an evaluation of …
SSTR2 expression in olfactory neuroblastoma: clinical and therapeutic implications
V Cracolici, EW Wang, PA Gardner… - Head and Neck …, 2021 - Springer
Abstract Somatostatin receptor 2 (SSTR2) expression has previously been documented in
olfactory neuroblastoma (ONB). Here, we fully characterize SSTR2 expression in ONB and …
olfactory neuroblastoma (ONB). Here, we fully characterize SSTR2 expression in ONB and …
[HTML][HTML] Time-activity data fitting in molecular radiotherapy: methodology and pitfalls
Absorbed radiation doses are essential in assessing the effects, eg safety and efficacy, of
radiopharmaceutical therapy (RPT). Patient-specific absorbed dose calculations in the target …
radiopharmaceutical therapy (RPT). Patient-specific absorbed dose calculations in the target …
International consensus statement on allergy and rhinology: Sinonasal tumors
EC Kuan, EW Wang, ND Adappa… - International forum of …, 2024 - Wiley Online Library
Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …
challenge to clinicians and represent a model area for multidisciplinary collaboration in …
[HTML][HTML] PET/CT imaging in treatment planning and surveillance of sinonasal neoplasms
S Akay, JH Pollard, A Saad Eddin, A Alatoum… - Cancers, 2023 - mdpi.com
Simple Summary Sinonasal cancers are rare types of cancer that are often detected at a late
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …
stage, making them difficult to treat. To monitor these cancers closely, advanced imaging …
Emerging concepts in sinonasal tumor research
DC Lopez, AE Wadley… - Current opinion in …, 2022 - journals.lww.com
Studies reviewed here detail promising results of the most current and novel
characterization of SNUC, ITAC, and ONB genetic and molecular landscapes, which have …
characterization of SNUC, ITAC, and ONB genetic and molecular landscapes, which have …
[HTML][HTML] The current role of peptide receptor radionuclide therapy in meningiomas
CK Fodi, J Schittenhelm, J Honegger… - Journal of Clinical …, 2022 - mdpi.com
Meningiomas are the most common primary intracranial tumors. The majority of patients can
be cured by surgery, or tumor growth can be stabilized by radiation. However, the …
be cured by surgery, or tumor growth can be stabilized by radiation. However, the …